Sarepta Therapeutics | SRPT - 销售成本

金融业

USD

USD 3.18B

现金及等价物

USD 464.45M

USD 109.46M

USD 2.31B

USD 499.16M

USD 1.04B

USD 358.43M

USD -252.2M

1.37K

EPS每股收益

USD 3.16

股本和储备

USD 1.51B

USD 621.34M

债务利息支出

USD 20.84M

USD 8.74M

USD 838.16M

USD 1.78B

USD 330.96M

USD 372.37M

USD 358.43M

普通股股本

USD 105.57M

27.27

USD 343.17M

USD 730.8M

销售和管理费用

USD 54.03M

USD 1B

贸易债权人

USD 70.38M

应收帐款人

USD 547.91M

	销售成本	更改		日
Acadia Pharmaceuticals	USD 24.79M		1.43M	2026-03
Agios Pharmaceuticals	USD 1.32M		560K	2026-03
Alnylam Pharmaceuticals	USD 211.12M		56.6M	2026-03
Amgen	USD 1.6B		187M	2026-03
BioCryst Pharmaceuticals	USD 9.52M		7.34M	2025-12
Biogen	USD 797.5M		302M	2026-03
BioMarin Pharmaceutical	USD 199.48M		37.93M	2026-03
Daiichi Sankyo	JPY 118.28B		37.7B	2025-12
Eli Lilly	USD 3.58B		205M	2026-03
Esperion Therapeutics	USD 27.85M		13.43M	2025-12
Gilead Sciences	USD 1.44B		174M	2026-03
Incyte	USD 104.5M		16.68M	2026-03
Insmed	USD 49.5M		3.34M	2026-03
Ionis Pharmaceuticals	USD 3M		5M	2026-03
Moderna	USD 955M		503M	2026-03
Nektar Therapeutics	USD 4.43M		5.3M	2024-09
Neurocrine Biosciences	USD 13.8M		3.8M	2026-03
Novavax	USD 22.1M		608K	2025-12
Pfizer	USD 4.59B		1.7B	2026-03
PTC Therapeutics	USD 39.61M		23.31M	2026-03
Regeneron Pharmaceuticals	USD 669.4M		84.8M	2026-03
Roche Holding	CHF 8.48B		4.61B	2025-12
Sangamo BioSciences	2.42M		1.11M	2024-06
Sanofi	EUR 3.67B		621M	2026-03
Sarepta Therapeutics	USD 109.46M		289.93M	2026-03
Ultragenyx Pharmaceutical	USD 30M		1000K	2026-03
Vertex Pharmaceuticals	USD 392.8M		73.2M	2026-03